Journal de la Faculté de Médecine
Volume 4, Numéro 1, Pages 527-532
2020-06-21
Authors : Nachi Mourad . Kihek Ibtissem . Entasoltan Badra . Taibi Karima . Guella Mohamed Djaoued . Abed Amine . Boukhatmi Yasmine . Bekadja Mohamed Amine .
Aim. In chronic myeloid leukemia (CML), the research of BCR-ABL1 fusion transcript became essential to confirm the molecular diagnosis. In this study, we describe the different types of BCR-ABL1 fusion transcripts found in CML patients in West Algerian patients. Methods. A total of 167 CML suspected patients were included in our study. A qualitative research on fusion transcripts was carried out by reverse transcription polymerase chain reaction (RT-PCR) technique in the biochemistry laboratory of Oran’s university hospital establishment. Results. The two types of major BCR-ABL1 fusion transcript Mb3a2 and Mb2a2 were present in 59,8 % and 36,4% of cases respectively. Two patients (1,8%) had an atypical and rare transcript type e19a2 and two others (1,8%) co-expressed b3a2 and b2a2 transcript types. Conclusion. Our study confirmed the data in the literature with a higher incidence of the major transcript.
Chronic Myeloid Leukemia, multiplex RT-PCR, BCR-ABL1 Transcript, rare fusion transcripts, Co-expression b3a2/b2a2
Baudin Bruno
.
Isnard Françoise
.
Mailloux Agnès
.
Zunic Patricia
.
Tahraoui Abdelkrim
.
Bénéteau-burnat Bénédicte
.
Garderet Laurent
.
Vaubourdolle Michel
.
pages 24-32.
Aitouche Moh-amokrane
.
Djeddi Mounir
.
Djeddi Mabrouk
.
Mihoubi Abdelhafid
.
pages 119-138.
Mazari Halima
.
pages 97-101.
Guettaia Seyf Eddine
.
pages 666-676.